# A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditions

> **NCT04718805** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 22 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Darunavir
- **DRUG:** Cobicistat
- **DRUG:** Darunavir/Cobicistat FDC

## Key facts

- **NCT ID:** NCT04718805
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-26
- **Primary completion:** 2021-03-01
- **Final completion:** 2021-03-01
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2025-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04718805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04718805, "A Study of Darunavir in the Presence of Cobicistat When Administered as a Fixed Dose Combination Under Fed Conditions". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04718805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*